Progesterone Test: When to Order It and What Your Results Mean

What Progesterone Actually Is and Why It Matters for Women

Progesterone is a steroid hormone made primarily by the corpus luteum after ovulation, and then by the placenta from about 10 weeks of pregnancy onward. It is not just a "pregnancy hormone." It prepares the uterine lining to receive an embryo, modulates the immune response during implantation, influences mood and sleep through its conversion to the neurosteroid allopregnanolone, and works in constant conversation with estrogen throughout your reproductive life.

Without progesterone, the endometrium cannot maintain itself after ovulation. This is why a woman with consistently low post-ovulation progesterone may experience short cycles, premenstrual spotting, recurrent early loss, or simply never feel well in the second half of her cycle.

The test measures serum (blood) progesterone in nanograms per milliliter (ng/mL). Because progesterone is only made in meaningful amounts after ovulation, when and why you test it changes the interpretation entirely. A result of 0.5 ng/mL in a postmenopausal woman is expected; the same number in someone who is trying to conceive mid-cycle is cause for concern.

When to Order a Progesterone Test: Timing Is Everything

Day 21 Testing for Ovulation Confirmation

The classic clinical instruction is to draw progesterone on day 21 of a 28-day cycle. The reasoning: ovulation typically occurs around day 14, and the corpus luteum peaks about 7 days later. A serum progesterone above 3 ng/mL confirms that ovulation occurred, though many clinicians use a threshold of 10 ng/mL as evidence of adequate luteal-phase function.

This 3 ng/mL cutoff has been debated. The American Society for Reproductive Medicine notes that a single mid-luteal draw may underestimate luteal adequacy because progesterone is secreted in pulses, and levels can vary by more than 50% within a single day. Serial sampling on days 19, 21, and 23 gives a more accurate picture when luteal phase defect is the clinical question.

Adjusting for Cycle Length

Not every woman has a 28-day cycle. If your cycle is 35 days, your ovulation likely falls around day 21, making day 28 the right draw date. The practical rule: test 7 days before your expected next period, not on a fixed calendar day. Using a home LH monitor or basal body temperature chart to identify your ovulation day, then booking the blood draw exactly 7 days later, gives the most informative result.

Early Pregnancy and the 16-Week Shift

In confirmed or suspected pregnancy, progesterone is ordered for a different reason: to assess early pregnancy viability. A serum progesterone below 5 ng/mL in early pregnancy carries a sensitivity of roughly 85% for non-viable pregnancy, while a level above 25 ng/mL makes ectopic or failing pregnancy much less likely. Values between 5 and 25 ng/mL are a gray zone requiring serial hCG and ultrasound.

After about 10 weeks gestation, the placenta takes over progesterone production (the "luteal-placental shift"), and serum levels become less clinically useful for viability assessment. By the third trimester, progesterone can reach 100 to 200 ng/mL, a normal and expected rise.

Perimenopause: When Timing Gets Complicated

In perimenopause, cycle length becomes unpredictable. You may skip ovulation entirely some months (anovulatory cycles) and ovulate normally others. This means your day 21 draw could land in a completely different phase of a longer, irregular cycle and look falsely low.

A more clinically useful framework for perimenopausal women: track cycles with an LH monitor for at least two months, identify which cycles include an LH surge, then draw progesterone 7 days after the surge. If no LH surge occurs, the result of a low progesterone simply confirms anovulation for that cycle, which is expected and normal for this life stage. The Menopause Society (NAMS) acknowledges that anovulatory cycles increase in frequency during perimenopause, sometimes years before the final menstrual period.

Monitoring Hormone Therapy

If you are on cyclic progestogen as part of hormone replacement therapy (HRT), your provider may order serum progesterone to confirm adequate endometrial protection. Oral micronized progesterone (Prometrium) produces detectable serum levels, though salivary and urinary testing correlates poorly with serum for HRT monitoring purposes, and serum remains the standard.

Normal Progesterone Ranges by Life Stage

Reference ranges vary by laboratory, but the following are widely cited across Endocrine Society and ACOG guidance:

| Life Stage | Approximate Normal Range | |---|---| | Follicular phase (days 1-13) | 0.1 to 0.9 ng/mL | | Mid-luteal phase (day 21) | 5 to 20 ng/mL (ovulation confirmed >3 ng/mL) | | First trimester | 11 to 44 ng/mL | | Second trimester | 25 to 83 ng/mL | | Third trimester | 58 to 214 ng/mL | | Postmenopause (untreated) | <1 ng/mL | | Oral micronized progesterone 200 mg/night | Variable; 2 to 25 ng/mL next morning |

These ranges are based on serum immunoassay; mass spectrometry (LC-MS/MS) methods, which are more precise, produce somewhat different absolute values. Always interpret your result against your own lab's reference range, not a generic table.

What the Numbers Mean at Each Stage

During the reproductive years, the mid-luteal value is your signal about ovulatory quality. A result between 3 and 10 ng/mL suggests ovulation occurred but luteal function may be suboptimal. Below 3 ng/mL on a properly timed draw suggests anovulation.

During early pregnancy, the trend matters as much as the absolute value. A single draw of 12 ng/mL that holds or rises is more reassuring than one that drops to 8 ng/mL a week later.

After menopause, the near-zero baseline is expected. A postmenopausal woman not on HRT with a progesterone above 3 ng/mL warrants investigation, as rare causes include adrenal tumors or ovarian tumors that secrete progesterone.

What Low Progesterone Means

Low progesterone on a properly timed draw tells you one of a few things: ovulation did not occur, the corpus luteum formed but is underperforming, or (in early pregnancy) the pregnancy may not be progressing normally.

Common Causes of Low Progesterone in Women

Anovulation. The most common cause. No ovulation means no corpus luteum, which means no progesterone surge. Polycystic ovary syndrome (PCOS) is the leading cause of anovulation in reproductive-age women, affecting approximately 8 to 13% of women globally. A low day-21 progesterone in a woman with irregular cycles is a strong signal to evaluate for PCOS with fasting insulin, testosterone, and pelvic ultrasound.

Luteal phase defect (LPD). The corpus luteum forms but does not produce enough progesterone for long enough. LPD is associated with recurrent implantation failure and early pregnancy loss. Diagnosis requires serial mid-luteal draws or endometrial biopsy showing delayed histologic maturation.

Hypothalamic suppression. Intense exercise, caloric restriction, high psychological stress, or low body weight can suppress GnRH pulsatility, preventing the LH surge needed for ovulation. Functional hypothalamic amenorrhea (FHA) is seen in athletes and women with eating disorders and produces consistently low progesterone alongside low LH and FSH.

Perimenopause. As the ovarian reserve declines, follicles recruited in a given cycle are more likely to fail before ovulating, producing a pattern of skipped or low progesterone months.

How to Raise Progesterone

The approach depends entirely on the cause.

For anovulation from PCOS, restoring ovulation is the goal. Letrozole 2.5 to 5 mg on cycle days 3-7 is now preferred over clomiphene for ovulation induction in PCOS per ASRM 2023 guidance, and successful ovulation will raise luteal progesterone naturally. Inositol supplementation (myo-inositol 4 g/day) has shown modest benefit in improving ovulatory function in PCOS in several small RCTs, though large confirmatory trials are still limited.

For luteal phase defect in women trying to conceive, exogenous progesterone supplementation is the standard approach. Options include:

• Vaginal progesterone gel (Crinone 8%) or suppositories (compounded 200-400 mg)
• Oral micronized progesterone (Prometrium 200 mg nightly)
• Intramuscular progesterone in oil (for ART cycles)

A 2021 Cochrane review found that luteal phase progesterone support in IVF significantly improves live birth rates compared to placebo, though evidence for luteal support in natural conception cycles is weaker and more heterogeneous.

For hypothalamic suppression, the target is restoring energy availability. Weight restoration, reducing training load, and behavioral support improve GnRH pulsatility and eventually restore spontaneous ovulation without exogenous hormones.

For perimenopausal low progesterone causing symptoms (heavy or irregular bleeding, poor sleep, premenstrual mood changes), cyclic oral micronized progesterone 100 to 200 mg on days 12-26 of the cycle is commonly prescribed, though evidence for this specific use in perimenopausal women with intact uteri is largely observational.

What High Progesterone Means

A high progesterone result is less common as a clinical complaint, but it does carry specific meaning depending on context.

Causes of Elevated Progesterone

Normal pregnancy. The most common cause of high progesterone is a healthy, advancing pregnancy. If you are pregnant and your progesterone is rising, this is reassuring.

Ovarian cysts. A corpus luteum cyst can continue secreting progesterone after the normal window. Luteal cysts are usually self-resolving within 1-2 menstrual cycles and rarely require intervention.

Congenital adrenal hyperplasia (CAH). In the non-classic (late-onset) form, a defect in 21-hydroxylase causes progesterone to accumulate as it cannot be converted normally. Non-classic CAH affects approximately 1 in 1,000 women and can present with symptoms very similar to PCOS, including hirsutism and irregular periods. Diagnosis requires a stimulated 17-hydroxyprogesterone level, not baseline progesterone.

Exogenous progesterone. If you are taking prescribed progesterone (HRT, luteal support, or the progesterone-only pill in high-dose form), your serum level will reflect this.

Adrenal or ovarian tumors. Rare. High progesterone in a postmenopausal woman not on HRT should prompt imaging.

How to Lower Progesterone

You rarely need to lower progesterone pharmacologically. Most causes resolve on their own (corpus luteum cysts), or the elevated level reflects a state that is either normal (pregnancy) or requires a different intervention (treating the underlying CAH or tumor). Providers do not routinely prescribe progesterone-lowering agents in women outside of specific oncology or research contexts.

Progesterone in Women With PCOS

PCOS deserves its own mention because the progesterone test is both diagnostic and monitoring in this population. Women with PCOS frequently present with the question of whether they ovulated in a given month. A mid-luteal progesterone below 3 ng/mL confirms anovulation and supports the diagnosis when combined with clinical or biochemical hyperandrogenism and polycystic ovarian morphology on ultrasound (Rotterdam criteria).

After ovulation induction, a rise in progesterone to above 10 ng/mL mid-luteal confirms the treatment worked. This serial monitoring is a standard part of ovulation induction protocols. Women with PCOS who do ovulate spontaneously may still have a shortened luteal phase and lower peak progesterone than ovulatory women without PCOS, which is one reason why luteal support is often added during fertility treatment even after documented ovulation.

Progesterone During Pregnancy and Lactation

This section applies to anyone who is pregnant, planning pregnancy, or in the postpartum period.

Pregnancy

Progesterone is not a teratogen. It is an essential hormone of pregnancy, and the body produces it in large amounts from very early on. Exogenous progesterone is used in several pregnancy contexts:

• Recurrent pregnancy loss (RPL). The PROMISE trial (Coomarasamy et al., NEJM 2015) found that vaginal progesterone did not significantly improve live birth rates in women with unexplained RPL overall. A pre-specified subgroup analysis in women with prior pregnancy loss and early pregnancy bleeding, however, suggested possible benefit. The subsequent PRISM trial (Coomarasamy et al., NEJM 2019) found a modest but statistically significant increase in live birth rate (72% vs 67%) with vaginal progesterone in women with early pregnancy bleeding and a history of loss.

• Preterm birth prevention. Vaginal progesterone 200 mg/night in women with a short cervix (<25 mm) before 24 weeks reduces preterm birth risk by approximately 45%, per the FIGO Working Group. 17-hydroxyprogesterone caproate (17-OHPC) is no longer recommended for singleton pregnancies after the PROLONG trial showed no benefit.

• ART luteal support. Progesterone supplementation from retrieval or transfer through 8-12 weeks is standard in all IVF protocols.

Oral micronized progesterone (Prometrium) contains peanut oil and is contraindicated in women with peanut allergy. Vaginal routes (Endometrin, Crinone, compounded suppositories) avoid this issue.

Lactation

Progesterone levels drop sharply after delivery, which is part of the hormonal signal that initiates lactation. This postpartum drop, combined with rising prolactin, is physiologically normal. Exogenous progesterone during breastfeeding is used cautiously. The progestin-only pill (norethindrone 0.35 mg) and the levonorgestrel IUD are both considered compatible with breastfeeding per ACOG and CDC Medical Eligibility Criteria, as systemic absorption to the infant is minimal. High-dose exogenous progesterone (such as the doses used for luteal support) has limited lactation safety data; most women completing a fertility cycle are not yet breastfeeding when these doses are used.

Contraception Note

Progesterone-containing contraceptives (progestin-only pills, hormonal IUDs, implants, injectables) suppress ovulation to varying degrees and will produce abnormal progesterone test results if you test mid-cycle while on them. If you need an accurate ovulatory progesterone assessment, your provider will need to know your current contraceptive method before interpreting the result.

Who Should Get a Progesterone Test

Women Who Benefit Most

• Women trying to conceive who want to confirm ovulation occurred
• Women with irregular or long cycles (suspected anovulation or PCOS)
• Women with a history of recurrent pregnancy loss (two or more losses)
• Women in early pregnancy with bleeding or pain to help assess viability
• Perimenopausal women with very irregular cycles, severe PMS, or heavy bleeding where anovulatory cycles are suspected
• Women on HRT with cyclic progestogen where endometrial protection needs to be confirmed

Who the Test Adds Less Value For

• Women on combined oral contraceptives (suppresses the entire HPO axis; testing is not informative for ovulation)
• Postmenopausal women not on HRT (low progesterone is expected and the result does not guide treatment)
• Women in the follicular phase before ovulation (the result will be low, and that tells you nothing about whether you will ovulate)

The Evidence Gap in Women's Health Research

Progesterone research has historically focused on pregnancy outcomes, and data specifically in perimenopausal symptom management and luteal phase support for natural cycles is far less solid than the IVF literature. Most luteal phase defect studies are small, use different diagnostic criteria, and were conducted in women undergoing fertility treatment. The Endocrine Society's 2015 clinical practice guideline on female androgen insufficiency noted that evidence for progesterone's role in non-reproductive symptoms (sleep, mood, cognition) remains largely observational. Women with perimenopausal sleep disruption or mood changes who are prescribed progesterone off-label for these symptoms should understand the evidence base is weaker than for its endometrial-protective role.